Celcuity Inc. retains a Buy rating following FDA approval of its drug REVTORPYK, which showed strong efficacy and safety compared to existing treatments. Despite a significant drop in share price from $119 to $68, positive mutant data supports the outlook. Management targets peak sales of $2.5 billion, with models suggesting substantial upside even at $1.2 billion based on US sales alone. Risks include IV administration, side effects, dilution from convertible notes, and Celcuity's first-time commercialization in a competitive market.
Celcuity's recent developments provide context for readers interested in health-sector stocks. As of Oct 30, 2026 16:51 WIB, among 150 priced US health-sector stocks tradable on Pluang, 73 rose and 70 fell. Notable movers include AstraZeneca plc (AZN) at USD 181.87 with a 1-day change of +4.28% and a typical hold time on Pluang of 126 days, Iovance Biotherapeutics Inc. (IOVA) at USD 9.16 with a -4.18% change and 3 days hold time, and Hims and Hers Health Inc (HIMS) at USD 28.46 with a -4.08% change and 23 days hold time. The most notable figure is AZN's 86% sell order activity on Pluang.
The National Advertising Division (NAD) reviewed advertising claims by Carpe after a challenge from Procter & Gamble. NAD upheld Carpe's $19.95 reference price for its Underarm Stick savings claims but recommended Carpe modify or stop other claims re...
The global dialysis machines market is forecasted to grow from $17.89 billion in 2026 to $31.54 billion by 2035, at a CAGR of 6.5%. Growth is fueled by rising chronic kidney disease cases, expanding dialysis infrastructure, and innovations like home ...
FirstCash Holdings reported a 28% year-over-year decline in operating income for its American First Finance segment and a 15% drop in lease and loan originations for Q3 2026. This led to a 14.75% stock price decline on October 22, 2026. The Law Offic...
Oxford Square Capital Corp. announced its financial results for Q3 2026, reporting a net asset value (NAV) per share of $1.21, down from $1.29 in Q2. The company declared monthly dividends of $0.015 per share for January, February, and March 2027. Ne...
As Halloween approaches, MADD Canada warns against impaired driving caused by alcohol, cannabis, or drugs, which leads to hundreds of deaths and thousands of injuries annually in Canada. The organization urges people to plan safe transportation if co...
